The pharmaceutical industry has long positioned itself as patient- or customer-focused. Our vision, mission and values statements are full of purpose-driven language, ethical intent, and references to ...

Shares in BridgeBio were ticking up today after it revealed data from its phase 3 trial of infigratinib in achondroplasia, ...

Private equity firm expands healthcare focus. Inflexion, a leading European mid-market private equity firm, appointed John ...

EVERSANA, a leading provider of commercialisation services to the global life sciences industry, has named Monica Avram as ...

According to Invest Europe, the challenge facing the European life sciences sector is clear - Europe currently accounts for ...

Zydus Lifesciences has reached a settlement agreement with Astellas in a patent dispute involving overactive bladder therapy Myrbetriq, which will allow its generic to remain on sale in the US.

In its main clinical trial, mRNA-1010 was shown to be 26.6% more effective than the comparator flu shot in adults aged 50 ...

PHARMAP 2026 addresses this transformation with a specialised session on patient-friendly design and its role in modern medicine. The event is scheduled for 20-21 April in Amsterdam. Trust and ...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas. Built from ...

Sanofi has announced a change of leadership, with former Merck KGaA chief executive Belén Garijo taking the helm of the French group from Paul Hudson, whose contract will not be renewed.

Madrigal Pharma was the first drugmaker to bring a treatment for metabolic dysfunction-associated steatohepatitis (MASH) to ...

Cary Claiborne, CEO of Adial Pharmaceuticals, believes his company’s bet on a precision treatment for AUD, for patients with a specific genetic biomarker, will help doctors and patients treat the ...